Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 168, Issue 3, Pages 947-961Publisher
ELSEVIER SCIENCE INC
DOI: 10.2353/ajpath.2006.050770
Keywords
-
Categories
Funding
- NIA NIH HHS [P30 AG010124, P01 AG009215, AG10124, AG09215] Funding Source: Medline
- NINDS NIH HHS [P01 NS044233, NS044233] Funding Source: Medline
Ask authors/readers for more resources
Heat shock proteins (Hsps) facilitate refolding of denatured polypeptides, but there is limited understanding about their roles in neurodegenerative diseases characterized by misfolded proteins. Because Parkinson's disease (PD), dementia with Lewy bodies, and multiple system atrophy are alpha-synucleinopathies characterized by filamentous alpha-synuclein (alpha-syn) inclusions, we assessed which Hsps might be implicated in these disorders by examining human brain samples, transgenic mouse models, and cell culture systems. Light and electron microscopic multiple-label immunohistochemistry showed Hsp90 was the predominant Hsp examined that co-localized with a-syn in Lewy bodies, Lewy neurites, and glial cell inclusions and that Hsp90 co-localized with a-syn filaments of Lewy bodies in PD. Hsp90 levels were most predominantly increased in PD brains, which correlated with increased levels of insoluble a-syn. These alterations in Hsp90 were recapitulated in a transgenic mouse model of PD-like alpha-syn pathologies. Cell culture studies also revealed that alpha-syn co-immunoprecipitated preferentially with Hsp90 and Hsc70 relative to other Hsps, and exposure of cells to proteasome inhibitors resulted in increased levels of Hsp90. These data implicate predominantly Hsp90 in the formation of alpha-syn inclusions in PD and related alpha-synucleinopathies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available